Following a recent MSP AG discussion, stakeholders are invited to contribute for the upcoming ACT-EU workshop on multiplicity in confirmatory two-arm and platform trials, taking place on 27 November 2026 at the EMA in Amsterdam.
🔍 How you can contribute:
1️⃣ Present a case study: Share examples illustrating complex multiplicity challenges in regulatory decision-making (especially within platform trials). Brief case-study presentations will fit into either:
–the “Aligning the Multiple Testing Strategy with the Study Primary Objectives” session
–the “Getting the Most Out of Clinical Trials While Managing Multiplicity” session (focused on totality of evidence, secondary endpoints, & multi-stakeholder needs)
2️⃣ Join as a panelist or a session chair: Express your interest in taking on an active role as a session chair or panelist.
📩 How to express interest: Please submit your interest or proposal to Olivier Collignon (olivier.collignon@ema.europa.eu) and Pietro D’Arcano (pietro.darcano@interim.ema.europa.eu) by 9 October (EOB), copying the CDDF secretariat (info@cddf.org)